VILLA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 9.141
AS - Asia 5.063
EU - Europa 3.729
SA - Sud America 726
AF - Africa 123
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 18.795
Nazione #
US - Stati Uniti d'America 8.646
SG - Singapore 1.727
IT - Italia 983
CN - Cina 874
HK - Hong Kong 819
VN - Vietnam 757
RU - Federazione Russa 616
BR - Brasile 542
DE - Germania 466
CA - Canada 413
IE - Irlanda 349
SE - Svezia 334
UA - Ucraina 216
GB - Regno Unito 190
IN - India 158
FR - Francia 147
ID - Indonesia 138
BD - Bangladesh 128
FI - Finlandia 99
AT - Austria 86
AR - Argentina 73
TR - Turchia 69
KR - Corea 59
IQ - Iraq 54
MX - Messico 47
ES - Italia 46
DK - Danimarca 41
ZA - Sudafrica 41
NL - Olanda 40
PL - Polonia 34
JP - Giappone 32
PK - Pakistan 32
SA - Arabia Saudita 32
PH - Filippine 29
VE - Venezuela 26
EC - Ecuador 25
UZ - Uzbekistan 23
IL - Israele 20
MA - Marocco 20
BE - Belgio 17
CO - Colombia 17
AE - Emirati Arabi Uniti 14
MY - Malesia 14
CH - Svizzera 13
CL - Cile 13
IR - Iran 11
TN - Tunisia 11
AZ - Azerbaigian 10
PY - Paraguay 10
TW - Taiwan 10
UY - Uruguay 9
EG - Egitto 8
JO - Giordania 8
KE - Kenya 8
JM - Giamaica 7
KZ - Kazakistan 7
OM - Oman 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
RO - Romania 6
RS - Serbia 6
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
EU - Europa 5
SN - Senegal 5
TH - Thailandia 5
AL - Albania 4
GR - Grecia 4
HN - Honduras 4
LB - Libano 4
LT - Lituania 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
AU - Australia 3
HU - Ungheria 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
Totale 18.771
Città #
Ann Arbor 1.457
Singapore 956
Hong Kong 805
Ashburn 712
Fairfield 663
Woodbridge 518
San Jose 420
Houston 390
Wilmington 351
Dublin 338
Frankfurt am Main 334
Milan 325
Toronto 285
Chandler 269
Cambridge 242
Seattle 242
New York 234
Ho Chi Minh City 225
Jacksonville 181
Santa Clara 179
Hanoi 177
Chicago 153
Dallas 153
Los Angeles 150
Princeton 148
Beijing 134
Jakarta 118
The Dalles 117
Council Bluffs 114
Hefei 114
Dearborn 98
Altamura 89
Lauterbourg 80
Lawrence 69
Nanjing 68
Moscow 67
Vienna 64
Buffalo 63
São Paulo 60
Seoul 55
Guangzhou 51
Ottawa 48
Orem 45
San Diego 44
Helsinki 38
Burlington 34
Rome 33
Lachine 29
Fremont 28
Da Nang 26
Dong Ket 26
Lappeenranta 26
Montreal 25
Grafing 24
Rio de Janeiro 24
Shanghai 24
Warsaw 24
Baghdad 23
Haiphong 23
Johannesburg 23
London 23
Tokyo 23
Chennai 22
Tashkent 22
Biên Hòa 21
Brooklyn 21
Atlanta 20
Andover 19
Salt Lake City 19
Shenyang 18
Nanchang 17
Thái Nguyên 17
Dhaka 16
Munich 16
Naples 16
Hyderabad 15
Hải Dương 15
Mexico City 15
Paris 15
Phoenix 15
Stockholm 15
Boardman 14
Brussels 14
Hebei 14
Kent 14
Mumbai 14
Denver 13
Ha Long 12
Lahore 12
Manchester 12
Norwalk 12
Poplar 12
Caracas 11
Nuremberg 11
Riyadh 11
Zurich 11
Ankara 10
Bologna 10
Brasília 10
Curitiba 10
Totale 12.442
Nome #
CHRNA2 and nocturnal frontal lobe epilepsy: Identification and characterization of a novel loss of function mutation 556
Analysis of human papillomavirus (HPV) 16 variants associated with cervical infection in Italian women 443
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 441
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 376
Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE) 346
Molecular and imaging biomarkers in Alzheimer’s disease: A focus on recent insights 346
Variants in CHRNB2 and CHRNA4 identified in patients with insular epilepsy 345
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 342
Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing 337
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges 334
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 332
Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update 332
Long Non-Coding RNAs and Related Molecular Pathways in the Pathogenesis of Epilepsy 331
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 311
Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics 307
Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease 294
Genetic architecture and molecular, imaging and prodromic markers in dementia with lewy bodies: State of the art, opportunities and challenges 287
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms 275
The synergistic relationship between Alzheimer's disease and sleep disorders: An update 270
Potassium channels and human epileptic phenotypes: An updated overview 269
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis 251
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis 235
Epigenetics in Alzheimer’s Disease: A Critical Overview 231
TIMP1 Overexpression in Ovarian Cancer Spheroids: Implications for Prognosis, Resistance, and Metastatic Potential 223
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders 218
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 216
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation 216
Exome Sequencing in an ADSHE Family: VUS Identification and Limits 212
C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia 211
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 211
Circulating miRNAs as potential biomarkers in Alzheimer’s disease 210
GSK3β genetic variability in patients with Multiple Sclerosis 209
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases 208
From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder 206
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 203
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 203
Immunoreactivity of muscarinic acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and kir channels in a model of epilepsy 203
Edaravone: A Novel Possible Drug for Cancer Treatment? 202
Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson’s disease: Molecular mechanisms connecting neuroinflammation to α-synuclein spreading pathology 201
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease 200
Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments 198
Homology Modelling, Molecular Docking and Molecular Dynamics Simulation Studies of CALMH1 against Secondary Metabolites of Bauhinia variegata to Treat Alzheimer’s Disease 196
Ehlers-Danlos Syndrome classical type: A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype 191
A novel role of cardiac inwardly rectifying potassium channels explaining autonomic cardiovascular dysfunctions in a cuprizone-induced mouse model of multiple sclerosis 191
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder 187
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 184
Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis 182
Insights into Dysregulated Neurological Biomarkers in Cancer 180
Psychosis in Parkinson’s Disease: A Lesson from Genetics 180
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder 180
GRN variability contributes to sporadic frontotemporal lobar degeneration 180
Candidate gene analysis of selectin cluster in patients with multiple sclerosis 180
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 179
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects 178
FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration 174
Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia 172
Ehlers-Danlos syndromes and epilepsy: An updated review 172
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration 171
Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with alzheimer's disease 170
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 168
Unraveling the role of inwardly rectifying potassium channels in the hippocampus of an Aβ(1-42)-infused rat model of Alzheimer's disease 166
Investigating cardiac morphological alterations in a pentylenetetrazol-kindling model of epilepsy 163
Epileptic seizures in autosomal dominant forms of Alzheimer's disease 161
Causal Frontotemporal Lobar Degeneration mutations: a novel MAPT mutation associated with the clinical phenotype of Progressive nonfluent Aphasia 159
Circulating miRNAs as potential biomarkers in Alzheimer's disease 157
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease 156
C9ORF72 repeat expansion is not detected in patients with multiple sclerosis 154
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 149
Tlr-mediated signal transduction and neurodegenerative disorders 149
Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration? 147
Arylsulfatase a (Asa) in parkinson’s disease: From pathogenesis to biomarker potential 147
A 45-year-old Italian male with p.(Gly1815Ser) FBN1 mutation causing a mild variant of Marfan syndrome: A case study 146
Novel exon 1 progranulin gene variant in Alzheimer's disease 146
New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders 144
Genetics and expression analysis of Sp4 transcription factor in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 144
Blood-based biomarkers in mild behavioral impairment: an updated overview 143
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration 143
The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype 142
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 140
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration 139
Biomarkers for alzheimer’s disease: Where do we stand and where are we going? 129
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 127
MCP-1 A-2518G polymorphism: Effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels 123
Transcription factor Sp1 is regulated by hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 120
CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration 120
Causal frontotemporal lobar degeneration mutations: a novel mutation in MAPT associated with non-fluent progressive aphasia phenotype 118
Multi-omics for the understanding of brain diseases 116
Microfluidic platforms to unravel mysteries of alzheimer’s disease: How far have we come? 111
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration 109
Expression and genetic analysis of microRNAs involved in multiple sclerosis 106
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 101
Ocular vascular changes: Choroidal thickness as an early biomarker for Alzheimer’s disease? 99
Riluzole inhibits ovarian cancer cell migration by altering extracellular matrix structure 38
Functional study of a mutant α2 subunit of the neuronal nicotinic acetylcholine receptor linked to sleep-related generalized seizures with cognitive deficit 34
Application of molecular imaging as potential prognostic biomarker for triple-negative breast cancer (TNBC) 31
Misfolded Proteins and Cognitive Decline: Mechanistic Insights into Neurodegenerative Disorders 29
Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights 25
Identification of a novel missense variant in a family with autosomal dominant sleep-related hypermotor epilepsy (ADSHE) 25
Alterations of inwardly rectifying potassium channels in an Aβ(1–42)-infused rat model of Alzheimer’s disease 17
Investigating the role of muscarinic acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and Kir channels in a pentylenetetrazol-kindling model of epilepsy 16
Totale 19.345
Categoria #
all - tutte 64.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 0 0 0 0 0 152 193
2021/20221.208 148 150 160 100 82 135 60 55 45 40 77 156
2022/20231.497 188 436 149 93 89 244 15 78 111 26 44 24
2023/20241.146 44 41 35 111 123 273 179 34 137 18 20 131
2024/20253.035 165 379 184 143 260 134 103 109 424 453 205 476
2025/20267.285 789 607 519 793 858 364 981 456 661 736 521 0
Totale 19.357